Top Markets
#1 Wiki Cat Wiki Cat +38.93%
#2 Siren Siren +35.55%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.15%
#4 Velvet Velvet +20.16%
#5 aPriori aPriori +19.57%
#6 Ribbita by Virtuals Ribbita by Virtuals +17.71%
#7 KUB Coin KUB Coin +17.43%
#8 PulseChain PulseChain +17.12%
#9 The Grays Currency The Grays Currency +14.52%
#10 Janction Janction +14.41%
Coin of the day
Wiki Cat Wiki Cat
Settings
Language
ENGLISH
Currency
USD
Theme
Arcoma AB Arcoma AB

Arcoma AB

ARCOMA
Rank in Stocks #31258
Arcoma AB is a global provider that designs, manufactures, and supplies... Arcoma AB is a global provider that designs, manufactures, and supplies cutting-edge radiology solutions. Their product line features advanced digital x-ray and radiography systems. These versatile systems are suitable for a wide array of radiographic applications and are utilized across various clinical environments, including general practice, musculoskeletal, thoracic, pediatric, and trauma/resuscitation units. The company distributes its products through a network of OEM partners. Arcoma AB was founded in 1990 and is headquartered in Växjö, Sweden.
Share Price
$0.96503214
Market Cap
$13.81M
Change (1 day)
1.89%
Change (1 year)
-0.17%
Country
SE
Trade Arcoma AB (ARCOMA)

Category

Healthcare
P/E ratio for Arcoma AB (ARCOMA)
P/E ratio as of 2026 TTM: 0
According to Arcoma AB latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Arcoma AB from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.77 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 34.86 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 20.90 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 52.64 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.